newsfilter
← Latest News
Business Wire·

New Research from RGA: GLP-1s Expected to Reduce US Mortality by 3.5% Over the Next 20 Years

By 2045, incretin-based drugs such as GLP-1s could reduce mortality in the US by 3.5% in a central scenario, 8.8% in an optimistic scenario, and 1.0% in a pessimistic scenario. Under the same central scenario,